Healthcare provider profile · identity verified

Timothy Shafer, M.D.

Family Practice · TOWNSHEND, VT · NPI 1053301721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	294	72
Metformin Hcl	Metformin Hcl	246	39
Lisinopril	Lisinopril	242	58
Amlodipine Besylate	Amlodipine Besylate	232	39
Hydrochlorothiazide	Hydrochlorothiazide	225	65
Metoprolol Succinate	Metoprolol Succinate	223	55
Levothyroxine Sodium	Levothyroxine Sodium	212	44
Losartan Potassium	Losartan Potassium	211	55
Furosemide	Furosemide	171	23
Omeprazole	Omeprazole	164	40
Buprenorphine Hcl	Buprenorphine Hcl	160	suppressed
Pravastatin Sodium	Pravastatin Sodium	154	35
Rosuvastatin Calcium	Rosuvastatin Calcium	153	44
Gabapentin	Gabapentin	151	28
Sertraline Hcl	Sertraline Hcl	151	11
Eliquis	Apixaban	145	25
Lamotrigine	Lamotrigine	136	suppressed
Oxycodone Hcl	Oxycodone Hcl	127	18
Lorazepam	Lorazepam	125	22
Aripiprazole	Aripiprazole	122	suppressed
Simvastatin	Simvastatin	119	21
Pantoprazole Sodium	Pantoprazole Sodium	112	25
Escitalopram Oxalate	Escitalopram Oxalate	111	21
Tamsulosin Hcl	Tamsulosin Hcl	108	28
Torsemide	Torsemide	104	24
Jardiance	Empagliflozin	100	20
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	97	12
Glipizide	Glipizide	96	suppressed
Allopurinol	Allopurinol	92	21
Zolpidem Tartrate	Zolpidem Tartrate	88	14
Fluoxetine Hcl	Fluoxetine Hcl	83	suppressed
Trulicity	Dulaglutide	81	suppressed
Prednisone	Prednisone	78	40
Spironolactone	Spironolactone	77	suppressed
Trazodone Hcl	Trazodone Hcl	70	20
Citalopram Hbr	Citalopram Hydrobromide	61	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	57	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	55	54
Farxiga	Dapagliflozin Propanediol	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	46	19
Diazepam	Diazepam	46	suppressed
Alprazolam	Alprazolam	45	suppressed
Mirtazapine	Mirtazapine	44	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	44	11
Clonazepam	Clonazepam	43	11
Pregabalin	Pregabalin	43	suppressed
Tramadol Hcl	Tramadol Hcl	41	11
Methylphenidate Hcl	Methylphenidate Hcl	39	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	16
Cephalexin	Cephalexin	36	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Ondansetron Odt	Ondansetron	34	suppressed
Potassium Chloride	Potassium Chloride	34	11
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	33	12
Latanoprost	Latanoprost	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Temazepam	Temazepam	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	29	23
Chlorthalidone	Chlorthalidone	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Famotidine	Famotidine	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Oxycontin	Oxycodone Hcl	27	suppressed
Risperidone	Risperidone	27	suppressed
Finasteride	Finasteride	26	suppressed
Linzess	Linaclotide	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Zaleplon	Zaleplon	25	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Carvedilol	Carvedilol	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Phenobarbital	Phenobarbital	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	12
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	11
Meloxicam	Meloxicam	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Ozempic	Semaglutide	18	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Acyclovir	Acyclovir	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lubiprostone	Lubiprostone	16	suppressed
Amoxicillin	Amoxicillin	15	11
Azithromycin	Azithromycin	15	suppressed
Estradiol	Estradiol	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Lactulose	Lactulose	14	suppressed
Primidone	Primidone	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Emgality Pen	Galcanezumab-Gnlm	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Xtandi	Enzalutamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error